These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 17489758

  • 1. Physico-chemical characterisation of different clindamycin phosphate samples.
    Vranić E, Planinsek O, Tivadar A, Hadzović S, Srcic S.
    Bosn J Basic Med Sci; 2007 May; 7(2):180-7. PubMed ID: 17489758
    [Abstract] [Full Text] [Related]

  • 2. Application of salt engineering to reduce/mask bitter taste of clindamycin.
    Barakh Ali SF, Dharani S, Afrooz H, Khan MA, Mohamed EM, Kohli K, Rahman Z.
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1871-1878. PubMed ID: 31549523
    [Abstract] [Full Text] [Related]

  • 3. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
    Müller T, Krehl R, Schiewe J, Weiler C, Steckel H.
    Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
    [Abstract] [Full Text] [Related]

  • 4. Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt.
    Pramar YV, Graves RA, Ledet GA, Phan KV, Bostanian LA, Mandal TK.
    Int J Pharm Compd; 2016 May; 20(5):421-425. PubMed ID: 28339377
    [Abstract] [Full Text] [Related]

  • 5. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL, Khan MA, Gupta A.
    Drug Dev Ind Pharm; 2015 May; 41(7):1156-64. PubMed ID: 25000481
    [Abstract] [Full Text] [Related]

  • 6. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM, Truong-Le V, Yee L, Pan E, Ao Y, Kalonia DS, Pikal MJ.
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [Abstract] [Full Text] [Related]

  • 7. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M, Milne M, Liebenberg W.
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [Abstract] [Full Text] [Related]

  • 8. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
    Windbergs M, Strachan CJ, Kleinebudde P.
    Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
    [Abstract] [Full Text] [Related]

  • 9. Calcium phosphates in pharmaceutical tableting. 1. Physico-pharmaceutical properties.
    Schmidt PC, Herzog R.
    Pharm World Sci; 1993 Jun 18; 15(3):105-15. PubMed ID: 8348106
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ, White BA.
    J Pharm Biomed Anal; 2006 Apr 11; 41(1):84-8. PubMed ID: 16298506
    [Abstract] [Full Text] [Related]

  • 11. Relationship between crystallization tendencies during cooling from melt and isothermal storage: toward a general understanding of physical stability of pharmaceutical glasses.
    Kawakami K, Harada T, Miura K, Yoshihashi Y, Yonemochi E, Terada K, Moriyama H.
    Mol Pharm; 2014 Jun 02; 11(6):1835-43. PubMed ID: 24731254
    [Abstract] [Full Text] [Related]

  • 12. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: Evaluation of film formulation and process set up.
    Albertini B, Bertoni S, Melegari C, Dolci LS, Passerini N.
    Int J Pharm; 2017 Jan 10; 516(1-2):380-391. PubMed ID: 27894987
    [Abstract] [Full Text] [Related]

  • 13. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT, Laaksonen T, Rades T, Aaltonen J, Peltonen L, Strachan CJ.
    Mol Pharm; 2014 Jan 06; 11(1):234-42. PubMed ID: 24224572
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M, Kato F, Matsuda Y.
    AAPS PharmSciTech; 2002 Jan 06; 3(4):E30. PubMed ID: 12916924
    [Abstract] [Full Text] [Related]

  • 17. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Frieb W.
    Eur J Pharm Biopharm; 2008 Aug 06; 69(3):793-807. PubMed ID: 18477504
    [Abstract] [Full Text] [Related]

  • 18. Inverse gas chromatography a tool to follow physicochemical modifications of pharmaceutical solids: Crystal habit and particles size surface effects.
    Cares-Pacheco MG, Calvet R, Vaca-Medina G, Rouilly A, Espitalier F.
    Int J Pharm; 2015 Oct 15; 494(1):113-26. PubMed ID: 26248145
    [Abstract] [Full Text] [Related]

  • 19. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM, Truong-Le V, Yee L, Nguyen L, Kalonia DS, Cicerone MT, Pikal MJ.
    J Pharm Sci; 2007 Aug 15; 96(8):1983-2008. PubMed ID: 17286290
    [Abstract] [Full Text] [Related]

  • 20. Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications.
    Chiou WL, Kyle LE.
    J Pharm Sci; 1979 Oct 15; 68(10):1224-9. PubMed ID: 512850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.